Open AccessImpaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Author(s) -
Euphrosyne GouzoulisMayfrank
Publication year - 2000
Publication title -
journal of neurology neurosurgery and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.391
H-Index - 206
eISSN - 1468-330X
pISSN - 0022-3050
DOI - 10.1136/jnnp.68.6.719
Subject(s) - ecstasy , mdma , cannabis , psychology , cognition , alertness , effects of sleep deprivation on cognitive performance , psychiatry , clinical psychology , developmental psychology
Ecstasy (3,4-methylenedioxymethamphetamine (MDMA) and related congerers: MDA, MDEA) is the name given to a group of popular recreational drugs. Animal data raise concern about neurotoxic effects of high doses of ecstasy on central serotonergic systems. The threshold dose for neurotoxicity in humans is not clear and serotonin is involved in several functions including cognition. The purpose of this study was to investigate cognitive performance in a group of typical recreational ecstasy users.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom